These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 28183591)
1. Graphene oxide-chitosan nanocomposites for intracellular delivery of immunostimulatory CpG oligodeoxynucleotides. Zhang H; Yan T; Xu S; Feng S; Huang D; Fujita M; Gao XD Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():144-151. PubMed ID: 28183591 [TBL] [Abstract][Full Text] [Related]
2. Polyethyleneimine-functionalized boron nitride nanospheres as efficient carriers for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides. Zhang H; Feng S; Yan T; Zhi C; Gao XD; Hanagata N Int J Nanomedicine; 2015; 10():5343-53. PubMed ID: 26346655 [TBL] [Abstract][Full Text] [Related]
3. Chitosan-coated boron nitride nanospheres enhance delivery of CpG oligodeoxynucleotides and induction of cytokines. Zhang H; Chen S; Zhi C; Yamazaki T; Hanagata N Int J Nanomedicine; 2013; 8():1783-93. PubMed ID: 23674892 [TBL] [Abstract][Full Text] [Related]
4. Chitosan nanoparticles fabricated through host-guest interaction for enhancing the immunostimulatory effect of CpG oligodeoxynucleotide. Wang Z; van Drunen Littel-van den Hurk S; Chen L Carbohydr Polym; 2021 Nov; 271():118417. PubMed ID: 34364558 [TBL] [Abstract][Full Text] [Related]
5. Nanodelivery systems for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides. Zhang H; Gao XD Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 2):935-946. PubMed ID: 27772724 [TBL] [Abstract][Full Text] [Related]
6. Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Bao H; Pan Y; Ping Y; Sahoo NG; Wu T; Li L; Li J; Gan LH Small; 2011 Jun; 7(11):1569-78. PubMed ID: 21538871 [TBL] [Abstract][Full Text] [Related]
7. Uniform small graphene oxide as an efficient cellular nanocarrier for immunostimulatory CpG oligonucleotides. Sun J; Chao J; Huang J; Yin M; Zhang H; Peng C; Zhong Z; Chen N ACS Appl Mater Interfaces; 2014 May; 6(10):7926-32. PubMed ID: 24712847 [TBL] [Abstract][Full Text] [Related]
8. Design and Characterization of Chitosan-Graphene Oxide Nanocomposites for the Delivery of Proanthocyanidins. Figueroa T; Aguayo C; Fernández K Int J Nanomedicine; 2020; 15():1229-1238. PubMed ID: 32110019 [TBL] [Abstract][Full Text] [Related]
9. Montmorillonite/graphene oxide/chitosan composite: Synthesis, characterization and properties. Yadav M; Ahmad S Int J Biol Macromol; 2015 Aug; 79():923-33. PubMed ID: 26047900 [TBL] [Abstract][Full Text] [Related]
10. Yeast β-D-glucan functionalized graphene oxide for macrophage-targeted delivery of CpG oligodeoxynucleotides and synergistically enhanced antitumor immunity. Cheng T; Yan T; Wu J; Wang Q; Zhang H Int J Biol Macromol; 2023 Apr; 234():123432. PubMed ID: 36716835 [TBL] [Abstract][Full Text] [Related]
11. A trustworthy CpG nanoplatform for highly safe and efficient cancer photothermal combined immunotherapy. Ming J; Zhang J; Shi Y; Yang W; Li J; Sun D; Xiang S; Chen X; Chen L; Zheng N Nanoscale; 2020 Feb; 12(6):3916-3930. PubMed ID: 32003377 [TBL] [Abstract][Full Text] [Related]
12. Well-dispersed chitosan/graphene oxide nanocomposites. Yang X; Tu Y; Li L; Shang S; Tao XM ACS Appl Mater Interfaces; 2010 Jun; 2(6):1707-13. PubMed ID: 20527778 [TBL] [Abstract][Full Text] [Related]
13. Nanoscale Zeolitic Imidazolate Framework-8 as Efficient Vehicles for Enhanced Delivery of CpG Oligodeoxynucleotides. Zhang H; Chen W; Gong K; Chen J ACS Appl Mater Interfaces; 2017 Sep; 9(37):31519-31525. PubMed ID: 28841289 [TBL] [Abstract][Full Text] [Related]
14. Layer-by-layer modification of magnetic graphene oxide by chitosan and sodium alginate with enhanced dispersibility for targeted drug delivery and photothermal therapy. Xie M; Zhang F; Peng H; Zhang Y; Li Y; Xu Y; Xie J Colloids Surf B Biointerfaces; 2019 Apr; 176():462-470. PubMed ID: 30682619 [TBL] [Abstract][Full Text] [Related]
15. Chitosan, magnetite, silicon dioxide, and graphene oxide nanocomposites: Synthesis, characterization, efficiency as cisplatin drug delivery, and DFT calculations. Abdel-Bary AS; Tolan DA; Nassar MY; Taketsugu T; El-Nahas AM Int J Biol Macromol; 2020 Jul; 154():621-633. PubMed ID: 32179117 [TBL] [Abstract][Full Text] [Related]
16. Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal/immune cancer therapy. Tao Y; Ju E; Ren J; Qu X Biomaterials; 2014 Dec; 35(37):9963-9971. PubMed ID: 25224368 [TBL] [Abstract][Full Text] [Related]
17. Characterisation and drug release performance of biodegradable chitosan-graphene oxide nanocomposites. Justin R; Chen B Carbohydr Polym; 2014 Mar; 103():70-80. PubMed ID: 24528702 [TBL] [Abstract][Full Text] [Related]
18. BN nanospheres functionalized with mesoporous silica for enhancing CpG oligodeoxynucleotide-mediated cancer immunotherapy. Zhang H; Cheng T; Lai L; Deng S; Yu R; Qiu L; Zhou J; Lu G; Zhi C; Chen J Nanoscale; 2018 Aug; 10(30):14516-14524. PubMed ID: 30024003 [TBL] [Abstract][Full Text] [Related]
19. Interferon alpha and CPG oligodeoxynucleotides elicit additive immunostimulatory and antitumor effects. Brown L; Roda J; Terrell C; Chaudhury AR; Crespin T; Carson WE; Lesinski GB Surgery; 2006 Aug; 140(2):297-306. PubMed ID: 16904983 [TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery. Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]